Selank

C33H57N11O9

Key Benefits

Anti-Anxiety

& Pain Reduction

Similar to benzodiazepine without the addiction. Improves generalized anxiety disorder (GAD) by enhancing GABA’s ability to inhibit excitability in the CNS. Also, protects enkephalins, which are endogenous peptides that help reduce pain.

Auto-Immune & Stress Relief

Affects the release of stress-related hormones, such as cortisol, and its negative biological impact. Quicker adaptation to the stressors. Restores healthy immune function in stress-induced immunoreactivity.

Anti-Viral

More effective at suppressing the reproduction of the H3N2 influenza (Flu) strain than recombinant IFN-α by modulating the immune system's response, particularly through its effect on cytokine gene expression, which enhances the body's ability to combat viral infections.

Anti-Depressant

Is a immunomodulator and adaptogen that suppresses the expression of IL-6 in depressed people. It affects levels of neurotransmitters like serotonin and dopamine, thereby improving mood and reducing symptoms of depression.

Biologic Description

Selank, an analog of the endogenous tetrapeptide tuftsin, is widely recognized for its potential in enhancing cognitive function, improving memory, and boosting mental clarity, often classified informally as a nootropic. Developed in the early 1990s at the Russian Academy of Sciences, Selank primarily gained attention for its anxiolytic properties, believed to be due to its modulation of neurotransmitters such as serotonin, dopamine, and GABA. This action not only reduces anxiety but also promotes a sense of calmness without inducing sedation or impairing cognitive abilities.

Intriguingly, Selank's influence extends beyond the central nervous system, as it interacts with the immune system by affecting gene expression and modulating cytokine balance. It has shown promise in the treatment of various conditions, including anxiety disorders, depression, and cognitive impairments. While approved for treating generalized anxiety disorder in Russia and some CIS states, it remains unreviewed by the FDA for clinical use in the U.S.

Selank's mechanisms are multifaceted. It alters the expression of GABA receptors, enhancing their affinity for GABA and thus mimicking the effects of benzodiazepines but without their side effects. It protects enkephalins, endogenous peptides involved in pain and anxiety reduction, by inhibiting enzymes that degrade them. This was evidenced in studies demonstrating its anxiolytic impact on certain mouse strains. Additionally, Selank suppresses the reproduction of the H3N2 influenza strain more effectively than traditional antiviral drugs, suggesting potential antiviral capabilities.

Clinical trials and studies have illuminated several benefits of Selank. Its anxiolytic effects are notable, with studies showing it reduces anxiety, increases enkephalin levels, and may enhance the effectiveness of other anxiety treatments. Its stress-relief potential is also significant, as it moderates stress-related hormone release and aids in stress adaptation. Furthermore, its cognitive-enhancing effects have been observed in learning-disabled rats, with improvements in learning, memory, and problem-solving skills.

Potential side effects include headaches and nausea. Nevertheless, its wide-ranging applications and ongoing research make it a compound of considerable interest in the scientific community.

Dosage Guidelines

With the current lack of established guidelines for human Selank dosing due to its unapproved status for such use, there is no definite dosage range or cycle length for Selank. Nevertheless, Dr. William Seeds, in his 2020 work, offered a sensible protocol drawing from a synthesis of available studies and personal observations in Selank therapy.

One of the recommended methods for administering Selank is through subcutaneous injections into adipose tissue. This method tends to have slower onset compared to other methods but potentially offers longer-lasting effects. The proposed dosage for subcutaneous injections ranges from 150mcg to 300mcg once per day.

In terms of the study duration for Selank, the lack of extensive clinical data makes it challenging to suggest a specific length. However, it's generally recommended to continue dosing for at least two weeks to observe the desired outcomes. While there's no strong evidence to support the need for cycling Selank, it might be wise to give research subjects a week-long break after every one or two weeks of administration as a precautionary measure.

150-300 mcg

Per Day

1-2 Weeks

Side Effects

Although Selank has limited safety data, it has shown minimal adverse effects in both human and animal studies. A peer-reviewed study highlighted that Selank offers the positive effects of low-dose benzodiazepines without their side effects.

Additionally, when used with phenazepam for anxiety disorders, Selank significantly reduced the side effects typically associated with phenazepam.

However, it's important to note that most Selank research, primarily conducted by scientists from the Russian Academy of Sciences, has been of short duration, possibly not allowing enough time for all adverse effects to appear.

Anecdotal reports mention side effects like headaches, pain or redness at the injection site, and nausea, but these are not conclusively linked to Selank.

Thus, researchers should exercise caution and thorough investigation before using Selank in their studies.

Where to Buy Premium Pure Peptides in the USA?

When it comes to Medical-Grade research peptides, our community only trusts one source in the USA: PurePeptides.vip. Verified for purity and authenticity, PurePeptides.vip is the gold standard for those who demand the highest quality.

🛍️SHOP NOW: PurePeptides.vip

Important: PurePeptides.vip only sells research peptides. They do not provide instructions, protocols, or additional supplies.

🎉 Exclusive Offer: Use code PROTOCOL at checkout for 10% off your first order!